PET imaging with multimodal upconversion nanoparticles.

A series of new upconversion nanoparticles have been functionalised with tumour-targeting molecules and metal chelates, prepared following standard peptidic and thiol chemistry. The targeting strategy has been delivered via the αvβ3 integrin, which is a heterodimeric cell surface receptor that is up-regulated in a variety of cancers, such as melanoma and breast cancer. The well-known DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) motif allows coordination to the radionuclide (68)Ga. Radiolabelling experiments were optimised under relatively mild conditions, and are rare amongst nanoparticulate materials. In vivo application of these probes in mouse tumour models revealed their potential as specific cancer contrast agents for PET imaging.

[1]  P. Choyke,et al.  In vivo multiple color lymphatic imaging using upconverting nanocrystals , 2009 .

[2]  Xiaogang Liu,et al.  Upconversion multicolor fine-tuning: visible to near-infrared emission from lanthanide-doped NaYF4 nanoparticles. , 2008, Journal of the American Chemical Society.

[3]  Markus P. Hehlen,et al.  Hexagonal Sodium Yttrium Fluoride Based Green and Blue Emitting Upconversion Phosphors , 2004 .

[4]  D. Cheresh,et al.  Involvement of integrin alpha V gene expression in human melanoma tumorigenicity. , 1992, The Journal of clinical investigation.

[5]  L. Salassa,et al.  Nano-functionalization of metal complexes for molecular imaging and anticancer therapy , 2013 .

[6]  R. Mewis,et al.  Biomedical applications of macrocyclic ligand complexes , 2010 .

[7]  Brian O Patrick,et al.  Acyclic chelate with ideal properties for (68)Ga PET imaging agent elaboration. , 2010, Journal of the American Chemical Society.

[8]  Wen-Yen Huang,et al.  Multimodality and nanoparticles in medical imaging. , 2011, Dalton transactions.

[9]  N. Long,et al.  The ubiquitous DOTA and its derivatives: the impact of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid on biomedical imaging. , 2013, Chemical communications.

[10]  C. Anderson,et al.  Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease. , 2010, Chemical reviews.

[11]  F. Tisato,et al.  Mononuclear six-coordinated Ga(III) complexes: A comprehensive survey , 2009 .

[12]  Thomas J Meade,et al.  Bioresponsive, cell-penetrating, and multimeric MR contrast agents. , 2009, Accounts of chemical research.

[13]  Jesse V Jokerst,et al.  Molecular imaging with theranostic nanoparticles. , 2011, Accounts of chemical research.

[14]  F. Auzel.  Upconversion and anti-Stokes processes with f and d ions in solids. , 2004, Chemical reviews.

[15]  Soonhag Kim,et al.  Development of a quadruple imaging modality by using nanoparticles. , 2009, Chemistry.

[16]  Jesse D. Ziebarth,et al.  Understanding the protonation behavior of linear polyethylenimine in solutions through Monte Carlo simulations. , 2010, Biomacromolecules.

[17]  Hao Hong,et al.  Molecular imaging and therapy of cancer with radiolabeled nanoparticles. , 2009, Nano today.

[18]  Barjor Gimi,et al.  Molecular and functional imaging of cancer: advances in MRI and MRS. , 2004, Methods in enzymology.

[19]  Piotr Walczak,et al.  Personalized nanomedicine advancements for stem cell tracking. , 2012, Advanced drug delivery reviews.

[20]  G. Lucignani.  Labeling peptides with PET radiometals: Vulcan’s forge , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[21]  Jaetae Lee,et al.  In Vivo Imaging of Sentinel Nodes Using Fluorescent Silica Nanoparticles in Living Mice , 2010, Molecular Imaging and Biology.

[22]  Weibo Cai,et al.  Nanoplatforms for targeted molecular imaging in living subjects. , 2007, Small.

[23]  Flora L Thorp-Greenwood,et al.  Multimodal radio- (PET/SPECT) and fluorescence imaging agents based on metallo-radioisotopes: current applications and prospects for development of new agents. , 2011, Dalton transactions.

[24]  D. Fernig,et al.  Long-term tracking of cells using inorganic nanoparticles as contrast agents: are we there yet? , 2012, Chemical Society reviews.

[25]  Yun Sun,et al.  Fluorine-18-labeled Gd3+/Yb3+/Er3+ co-doped NaYF4 nanophosphors for multimodality PET/MR/UCL imaging. , 2011, Biomaterials.

[26]  S. Gambhir,et al.  Molecular imaging in living subjects: seeing fundamental biological processes in a new light. , 2003, Genes & development.

[27]  T. Meade,et al.  Supramolecular Chemistry in Biological Imaging In Vivo , 2012 .

[28]  Qing Peng,et al.  Lanthanide-doped nanocrystals: synthesis, optical-magnetic properties, and applications. , 2011, Accounts of chemical research.

[29]  Zhuang Liu,et al.  Upconversion nanophosphors for small-animal imaging. , 2012, Chemical Society reviews.

[30]  M. Bawendi,et al.  Renal clearance of quantum dots , 2007, Nature Biotechnology.

[31]  René M. Botnar,et al.  Magnetic conjugated polymer nanoparticles as bimodal imaging agents. , 2010, Journal of the American Chemical Society.

[32]  Jinwoo Cheon,et al.  Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology. , 2008, Accounts of chemical research.

[33]  Feng Wang,et al.  Synthesis of polyethylenimine/NaYF4 nanoparticles with upconversion fluorescence , 2006 .

[34]  Qian Liu,et al.  18F-Labeled magnetic-upconversion nanophosphors via rare-Earth cation-assisted ligand assembly. , 2011, ACS nano.

[35]  C. Robic,et al.  Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. , 2008, Chemical reviews.

[36]  D. Salvo,et al.  Validation of (68)Ge/(68)Ga generator processing by chemical purification for routine clinical application of (68)Ga-DOTATOC. , 2008, Nuclear medicine and biology.

[37]  A. Kjaer,et al.  68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers. , 2012, Nuclear medicine and biology.

[38]  Angelique Louie,et al.  Multimodality imaging probes: design and challenges. , 2010, Chemical reviews.

[39]  Thomas J. Meade,et al.  Multimodal MRI contrast agents , 2007, JBIC Journal of Biological Inorganic Chemistry.

[40]  Jesse V Jokerst,et al.  Nanoparticle PEGylation for imaging and therapy. , 2011, Nanomedicine.

[41]  Zhichuan J. Xu,et al.  Synthesis, Functionalization, and Biomedical Applications of Multifunctional Magnetic Nanoparticles , 2010, Advanced materials.

[42]  B. Hamm,et al.  Modification of Aminosilanized Superparamagnetic Nanoparticles: Feasibility of Multimodal Detection Using 3T MRI, Small Animal PET, and Fluorescence Imaging , 2009, Molecular Imaging and Biology.

[43]  J. Karp,et al.  Nanoparticle-based monitoring of cell therapy , 2011, Nanotechnology.

[44]  Yun Sun,et al.  Fluorine-18 labeled rare-earth nanoparticles for positron emission tomography (PET) imaging of sentinel lymph node. , 2011, Biomaterials.

[45]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[46]  Wei Feng,et al.  Upconversion luminescence imaging of cells and small animals , 2013, Nature Protocols.

[47]  David A. Cheresh,et al.  Integrins in cancer: biological implications and therapeutic opportunities , 2010, Nature Reviews Cancer.

[48]  J. Frangioni.  In vivo near-infrared fluorescence imaging. , 2003, Current opinion in chemical biology.

[49]  Zahi A Fayad,et al.  Multifunctional imaging nanoprobes. , 2010, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[50]  Xiaogang Liu,et al.  Recent advances in the chemistry of lanthanide-doped upconversion nanocrystals. , 2009, Chemical Society reviews.

[51]  Zhuang Liu,et al.  Polymer encapsulated upconversion nanoparticle/iron oxide nanocomposites for multimodal imaging and magnetic targeted drug delivery. , 2011, Biomaterials.

[52]  R. Baum,et al.  Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals? , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[53]  Sanjiv S Gambhir,et al.  A molecular imaging primer: modalities, imaging agents, and applications. , 2012, Physiological reviews.

[54]  Antony K. Chen,et al.  Superparamagnetic Iron Oxide Nanoparticle Probes for Molecular Imaging , 2006, Annals of Biomedical Engineering.

[55]  Nicholas J Long,et al.  'Two is better than one'--probes for dual-modality molecular imaging. , 2009, Chemical communications.

[56]  Bradley D. Smith,et al.  Squaraine-derived rotaxanes: sterically protected fluorescent near-IR dyes. , 2005, Journal of the American Chemical Society.